Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination

Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Richard Todd, Johnson, Lee, Billotti, Jamie, Foulds, Georgia, Ketels, Taryn, Heard, Kennon, Calvello Hynes, Emilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Emergency Physicians. 2021
Materias:
Infectious Disease/Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253724/
https://www.ncbi.nlm.nih.gov/pubmed/34226070
http://dx.doi.org/10.1016/j.annemergmed.2021.04.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253724/
https://www.ncbi.nlm.nih.gov/pubmed/34226070
http://dx.doi.org/10.1016/j.annemergmed.2021.04.035

Ejemplares similares